Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Deregulation of the cell cycle by CDC20 mutations and its implications on rare malignant ovarian germ cell tumourigenesis
FY 2016-17
Summary
Faithful replication and segregation of chromosomes into daughter cells are critical for successful cell division. Before a cell divides, a series of mechanistic checkpoints ensures that the cell is ready for division. The spindle assembly checkpoint (SAC) prevents duplicated chromosomes that are not yet all attached to the cell's spindle fibres from segregating. When all chromosomes are attached, the CDC20 protein activates the anaphase-promoting protein complex (APC/C), whose activity allows the duplicated chromosomes to separate to opposite ends of the cell. Upon cell division, each daughter cell would have a chromosome number identical to that of the parent cell. SAC proteins inhibit CDC20 from activating APC/C until attachment of the last chromosome to the spindle fibres. Thus, SAC is a critical control for the timing of chromosome segregation, maintaining proper chromosome counts in daughter cells. Deregulation of SAC can cause aneuploidy (abnormal number of chromosomes) in cells. Aneuploidy has many pathological implications including cancer. My lab is collaborating with Dr. William Foulkes, a hereditary cancer geneticist who is elucidating genetic causes for rare familial malignant ovarian germ cell tumours (mOGCTs). The lab of Dr. Foulkes has pinpointed two different candidate mutations in the CDC20 gene in mOGCT patients from two different families. We hypothesize that the CDC20 mutations in the patients allow CDC20 to over-activate APC/C by rendering CDC20 insensitive to SAC, which leads to abnormal chromosome segregation and aneuploidy in cells. My research goal is to uncover the molecular mechanism by which the CDC20 mutants override the SAC and determine whether they have causal roles in tumour growth in mouse models.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367070
Name
Chen Owen J
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Deregulation of the cell cycle by CDC20 mutations and its implications on rare malignant ovarian germ cell tumourigenesis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anaphase Promoting Complex/Cyclosome (Apc/C); Cell Cycle; Cell-Division Cycle Protein 20 (Cdc20); Chromosomal Instability; Malignant Ovarian Germ Cell Tumour (Mogct); Mitosis; Mitotic Checkpoint Complex (Mcc); Mitotic Slippage; Spindle Assembly Checkpoint (Sac); Tumourigenesis
Abstract
Faithful replication and segregation of chromosomes into daughter cells are critical for successful cell division. Before a cell divides, a series of mechanistic checkpoints ensures that the cell is ready for division. The spindle assembly checkpoint (SAC) prevents duplicated chromosomes that are not yet all attached to the cell's spindle fibres from segregating. When all chromosomes are attached, the CDC20 protein activates the anaphase-promoting protein complex (APC/C), whose activity allows the duplicated chromosomes to separate to opposite ends of the cell. Upon cell division, each daughter cell would have a chromosome number identical to that of the parent cell. SAC proteins inhibit CDC20 from activating APC/C until attachment of the last chromosome to the spindle fibres. Thus, SAC is a critical control for the timing of chromosome segregation, maintaining proper chromosome counts in daughter cells. Deregulation of SAC can cause aneuploidy (abnormal number of chromosomes) in cells. Aneuploidy has many pathological implications including cancer. My lab is collaborating with Dr. William Foulkes, a hereditary cancer geneticist who is elucidating genetic causes for rare familial malignant ovarian germ cell tumours (mOGCTs). The lab of Dr. Foulkes has pinpointed two different candidate mutations in the CDC20 gene in mOGCT patients from two different families. We hypothesize that the CDC20 mutations in the patients allow CDC20 to over-activate APC/C by rendering CDC20 insensitive to SAC, which leads to abnormal chromosome segregation and aneuploidy in cells. My research goal is to uncover the molecular mechanism by which the CDC20 mutants override the SAC and determine whether they have causal roles in tumour growth in mouse models.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chen, Owen J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~